The Lung Cancer Clinical Masterclass Series UK

Episode 12 - April 2024 - Lung Cancer Masterclass Series UK

In our final episode of the series we are joined by Dr Nadza Tokaca from The Royal Marsden Hospital, London, who discussuses First-Line Strategies for Pleural and Peritoneal Mesothelioma. We will also hear from Dr Dean Fennell from The University of Leicester, Leicestershire, who will present on Strategies for Pre-Treated Mesothelioma: Current Standards and Future Directions. It is co-chaired by Prof Raffaele Califano, from The Christie, Manchester. Our two guest speakers engage in a disucssion to close the episode.

Episode 11 - March 2024 - Lung Cancer Masterclass Series UK

This month we are joined by Dr Anna Minchom from the Institute of Cancer Research and the Royal Marsden Hospital, London, who discusses Targeting RET and MET Positive Advanced NSCLC. We will also hear from Prof Alastair Greystoke from the Northern Centre for Cancer Care, Newcastle, who will present on Targeting EGFR exon-20, NTRK and HER2 Positive Advanced NSCLC. It is co-chaired by Prof Samreen Ahmed, from University Hospitals Leicester. Our two guest speakers engage in a disucssion to close the episode.

Episode 10 - February 2024 - Lung Cancer Masterclass Series UK

This month we are joined by Dr Tanya Ahmad from University College London Hospitals, who discusses Treatment of BRAF-Mutant NSCLC. We will also hear from Dr Helen Adderley from The Christie, Manchester, who will present on Genomic Screening for Lung Cancer: Treatment of KRAS-Mutant NSCLC. It is co-chaired by Prof Raffaele Califano, from The Christie, Manchester. Our two guest speakers engage in a disucssion to close the episode.

Episode 9 - January 2024 - Lung Cancer Masterclass Series UK

Happy New Year! This month we will hear from Dr Yvonne Summers from The Christie, Manchester, who will provide insight on Standard Stratergies for Advanced ALK and ROS1-Mutant NSCLC. We are also joined by our co-chair, Prof Samreen Ahmed from University Hospitals Leicester, who presents on What's New in the Field of ALK and ROS1-Mutant NSCLC. It is co-chaired by Prof Raffaele Califano, from The Christie, Manchester. Our two guest speakers engage in a disucssion to close the episode.

Episode 8 - December 2023 - Lung Cancer Masterclass Series UK

This month we are joined by our co-chair, Prof Samreen Ahmed from University Hospitals Leicester, who presents on Standard Stratergies for Advanced EGFR-Mutant Stage IV NSCLC. We will also hear from Dr Carles Escriu from The Clatterbridge Cancer Centre, Liverpool, who will provide insight on What's New in the Field of EGFR-Mutant Stage IV NSCLC. It is co-chaired by Prof Raffaele Califano, from The Christie, Manchester. Our two guest speakers engage in a disucssion to close the episode.

Episode 7 - November 2023 - Lung Cancer Masterclass Series UK

This month we are joined by Dr Dionysis Papadatos-Pastos from University College London Hospitals, who discusses The Role of First-Line Immunotherapy or Chemoimmunotherapy for Advanced NSCLC. We will also hear from Dr Tim Benepal from St Georges University Hospitals, NHS FT, who will present on Second-Line Therapies for Advanced NSCLC. It is co-chaired by Prof Samreen Ahmed, from University Hospitals Leicester. Our two guest speakers engage in a disucssion to close the episode.

Episode 6 - October 2023 - Lung Cancer Masterclass Series UK

This month we are joined by Prof Corinne Faivre-Finn from The Christie, Manchester, who discusses Management of Limited-Stage Small Cell Lung Cancer. We will also hear from our co-chair Prof Raffaele Califano from The Christie and Manchester University Hospital, who will present on Management of Extensive-Stage Small Cell Lung Cancer - Chemo-Immunotherapy and Beyond. It is co-chaired by Prof Samreen Ahmed, from University Hospitals Leicester. Our two guest speakers engage in a disucssion to close the episode.

Episode 5 - September 2023 - Lung Cancer Masterclass Series UK

This month we are joined by Dr Fiona McDonald from the Royal Marsden Hospital, London, who discusses The Role of Concurrent Chemotherapy Followed by Durvalumab. We will also hear from Dr Shobhit Baijal from The University Hospital Birmingham NHS Trust, who will present on The Role of Perioperative Immunotherapy for Early-Stage/Locally Advanced NSCLC. It is co-chaired by Prof Samreen Ahmed, from University Hospitals Leicester. Our two guest speakers engage in a disucssion to close the episode.